SIGHTINGS


 
Sheep Cloned With Human Genes!
(Just Imagine What's Being/Been Done In Secret Labs)
12-19-97
 
 
WASHINGTON (AP) - The Scottish scientists who cloned Dolly have now produced Molly and Polly, two lambs cloned with a human gene so their milk will contain a blood-clotting protein that can be extracted for use in treating human hemophilia.
 
Molly and Polly were born in July and Dr. Ian Wilmut of the Roslin Institute
in Scotland said his team should know by spring if the lambs' milk will
contain useful quantifies of factor IX, a protein that helps blood to clot.
 
Wilmut and his team announced the cloning achievement in a report in the
journal Science to be published Friday.
 
Experts say the creation of Molly and Polly is the logical next step following
last year's cloning of Dolly, the first mammal cloned from an adult cell. The
new work could prove that cloning is an efficient way to create herds of cows
or flocks of sheep that act as drug-making factories.
 
Wilmut said Molly and Polly were produced with the same technique, called
nuclear transfer, used to make Dolly, but the original cell used to produce
the lambs came from a sheep fetus instead of from an adult animal.
 
In nuclear transfer, scientists remove the nucleus from an egg and replace it
with the nucleus from another cell. The egg is then placed into the uterus of
a surrogate mother that gives birth to an offspring that has only the genes of
the original cell.
 
In Dolly, the original cell came from an adult ewe's udder.
 
For Molly and Polly, Wilmut said his team took the original cell from a
26-day-old sheep fetus. Into this cell, the researchers inserted a human gene
for factor IX, linked to a sheep gene that increases milk production. They
also put into the cell a marker, a gene that causes resistance to an
antibiotic.
 
The manipulated cell was then nurtured so it replicated to thousands of cells.
 
Wilmut said the team then added an antibiotic to identify those cells that
included the antibiotic-resistant gene. These cells were separated from the
rest.
 
A total of 425 of these gene-modified cells were then placed into eggs that
had had their nucleus removed. These eggs were cultured for five to six days,
growing to an early embryo stage.
 
Wilmut said 62 embryos were then implanted into surrogate mother sheep.
 
From these, six lambs were born. Three contained both the human gene and the
marker gene. One of these lambs died, leaving only Molly and Polly.
 
``The new lambs are identical to each other and identical to the original
fetus except for the new gene that we introduced,'' said Wilmut.
 
Wilmut said the lambs will be allowed to grow normally and then given shots in
the spring to induce lactation. This will enable the researchers to test their
milk for the human factor IX. He said the lambs will mature by October and
will be mated so they will produce lambs in February of 1999.
 
``By then, we should have a good idea of the milk volume and the yield of the
useful protein from these animals,'' said Wilmut.
 
The selective breeding of Molly and Polly and their offspring could lead to a
whole flock of sheep, all of which produce human factor IX in their milk, he
said.
 
The lambs are the first animals cloned to produce human drugs in their milk,
but other techniques have been used to create drug-making animals. Several
companies are now testing cystic fibrosis and heart attack drugs that come
from the milk of genetically engineered sheep or goats. These animals,
however, were produced by injecting genes into a fertilized egg and then
implanting the egg in a surrogate mother, a technique less efficient than the
Roslin Institute's cloning. Only about 2 percent of such eggs grow to live
animals and only a small percentage of the survivors actually contain the
target genes.
 
Bruce Altrock, a researcher at Amgen Inc., a leading U.S. pharmaceutical gene
research lab, said producing Molly and Polly ``is a significant development,''
but that the Roslin researchers have yet to prove the lambs will produce
useful levels of drug in their milk.
 
Dr. Robert Foote, an animal gene researcher at Cornell University, said the
Roslin scientists may have developed a short-cut to making animals that
produce drugs. Others have done it with more expensive, less efficient
techniques, he said, ``but this is the first time it has been accomplished
with cloning techniques.''
 
He said, however, that the experiment's value will be known only after the
scientists prove Molly and Polly develop as normal sheep and retain their
ability to make useful amounts factor IX in their milk.


Email  eotl@west.net Homepage
Alt-Health